ARCHIVES

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

This article is from The Cancer Letter archive.

Vol. 37 No. 26 | July 1, 2011

Download PDF Visit The Full Archive

Related Articles

DCE Board Oks Concept For Three Contracts In Radiation Epidemiology

June 29, 1984

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

DeVita: It Was Time To Go, and The Action Is Hot At Memorial: Says He’ll Work Well With Paul Marks

August 19, 1988

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010